5Liu Y,,Ye X,Zhang H,et al.Antimicrobial susceptibility of Myco-plasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai,China. Antimicrobial Agents and Chemotherapy . 2009
6Fogarty C,Torres A,Choudhri S,et al.Efficacy of moxifloxacin for treatment of penicillin-,macrolide- and multidrug-resistant Strepto-coccus pneumoniae in community-acquired pneumonia. International Journal of Clinical Practice . 2005
7ML Metersky,A Ma,PM Houck,DW Bratzler.Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest . 2007
7Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
8Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
9Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
10Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
